Evolent Health, Inc. (FRA:9EH)

Market Cap	473.75M -50.1%
Revenue (ttm)	1.84B -4.5%
Net Income	-447.33M
EPS	-3.98
Shares Out	n/a
PE Ratio	n/a
Forward PE	15.19
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	4.160
Previous Close	4.000
Day's Range	4.160 - 4.160
52-Week Range	1.890 - 8.450
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 6, 2026

About Evolent Health

Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, an...

• Industry: Prepackaged Software
• Founded: 2011
• Employees: 4,200
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 9EH

Financial Performance

In 2025, Evolent Health's revenue was $1.88 billion, a decrease of -26.56% compared to the previous year's $2.55 billion. Losses were -$579.40 million, 520.0% more than in 2024.

Financial numbers in USD

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 26, 2026

Data Sources Report a data error